Your enquiry has been submitted
Fraser HiCynth™ Broth w/ Supplements
Intended Use
Recommended for the selective enrichment of Listeria species from food samples.
Composition
| Ingredients | Gms / Litre |
|---|---|
| HiCynth Peptone No.3* | 15.000 |
| HiCynth Peptone No.5 * | 5.000 |
| Sodium chloride | 20.000 |
| Lithium chloride | 3.000 |
| Disodium hydrogen phosphate | 9.600 |
| Potassium dihydrogen phosphate | 1.350 |
| Esculin | 1.000 |
| Nalidixic acid | 0.010 |
| Acriflavin | 0.0125 |
| Ferric ammonium citrate | 0.500 |
| Final pH (at 25°C) | 7.2±0.2 |
**Formula adjusted, standardized to suit performance parameters
* Chemically defined peptones
Directions
Suspend 55.47 grams of dehydrated medium in 1000 ml purified / distilled water. Heat to boiling to dissolve the medium completely. DO NOT AUTOCLAVE. Cool to 45-50°C. Mix well and dispense as desired in sterile tubes or flasks.
Principle And Interpretation
Listeria species are widely distributed and are isolated from soil, decaying vegetable matter, sewage, water, animal feed, fresh and frozen poultry, meats, raw milk, cheese and asymptomatic human and animal carriers (11). Only Listeria monocytogenes from the genus Listeria; causes infections in humans. L. monocytogenes primarily causes meningitis, encephalitis or septicemia in humans (9,12). In pregnant women, Listeria monocytogenes often causes an influenza like bacteremic illness that, if untreated, may lead to ammionitis and infection of the fetus, resulting in abortion, still birth or premature birth. Contaminated foods are the primary vehicles of transmission (8).
Fraser HiCynth™ Broth w/ Supplements is based on the formulation by Fraser and Sperber (2). It is recommended for selective enrichment of Listeria species from foods. Fraser HiCynth™ Broth w/ Supplements is prepared by replacing animal and vegetable peptones with chemically defined peptones to avoid BSE/TSE risks associated with animal peptones.
This medium contains HiCynth Peptone No.3, HiCynth Peptone No.5 which provide essential nutrients like carbon and nitrogenous compounds including vitamins, amino acids and trace ingredients. Phosphates buffer the medium while sodium chloride maintains osmotic equilibrium. Nalidixic acid and Acriflavin inhibits the growth of gram-negative and gram-positive organisms respectively (5,6,7) except Listeria species (5,6,7). Listeria species hydrolyze esculin to glucose and esculetin. The latter combines with ferric ions of ferric ammonium citrate, resulting in the formation of 6-7 dihydroxycoumarin, a black brown complex. Ferric ammonium citrate also enhances the growth of L. monocytogenes (1). High salt tolerance due to sodium chloride of Listeria is used as means to inhibit the growth of Enterococci. Lithium chloride is also used to inhibit Enterococci, which also possess the ability to hydrolyze esculin.
Type of specimen
Food samples
Specimen Collection and Handling
For food samples, follow appropriate techniques for sample collection and processing as per guidelines (10).
After use, contaminated materials must be sterilized by autoclaving before discarding.
Warning and Precautions
Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/ face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling specimens. Safety guidelines may be referred in individual safety data sheets.
Limitations
- Due to nutritional variations, some strains may show poor growth.
- Further biochemical tests must be carried out for confirmation.
Quality Control
Appearance
Cream to yellow homogeneous free flowing powder
Colour and Clarity of prepared medium
Fluorescent yellow coloured clear solution.
Reaction
Reaction of 5.55% w/v aqueous solution at 25°C. pH: 7.2±0.2
pH
7.00-7.40
Cultural response
Cultural characteristics observed after an incubation at 35 - 37°C for 24-48 hours.
| Organism | Inoculum (CFU) |
Growth | Esculin Hydrolysis |
|---|---|---|---|
| Escherichia coli ATCC 25922 (00013*) | >=104 | inhibited | |
| Enterococcus faecalis ATCC 29212 (00087*) | 50-100 | none-poor | |
| Listeria monocytogenes subsp. serovar 1 ATCC 19111 (00020*) | 50-100 | good-luxuriant | positive reaction, blackening of medium |
| Listeria monocytogenes ATCC 19112 | 50-100 | good-luxuriant | positive reaction, blackening of medium |
| Listeria monocytogenes ATCC 19117 | 50-100 | good-luxuriant | positive reaction, blackening of medium |
| Listeria monocytogenes ATCC 19118 | 50-100 | good-luxuriant | positive reaction, blackening of medium |
| Staphylococcus aureus subsp. aureus ATCC 25923 (00034*) | 50-100 | none-poor |
Key: (*) Corresponding WDCM numbers.
Storage and Shelf Life
Store dehydrated and the prepared medium at 2-8°C. Use before expiry date on the label. On opening, product should be properly stored dry, after tightly capping the bottle in order to prevent lump formation due to the hygroscopic nature of the product. Improper storage of the product may lead to lump formation. Store in dry ventilated area protected from extremes of temperature and sources of ignition Seal the container tightly after use. Product performance is best if used within stated expiry period.
Disposal
User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical sample must be decontaminated and disposed of in accordance with current laboratory techniques (3,4).
| Product Name | Fraser HiCynth™ Broth w/ Supplements |
|---|---|
| SKU | MCD2002 |
| Product Type | HiCynth™ |
| Physical Form | Powder |
| Origin | Chemically defined (HiCynth™) |
| Packaging type | HDPE |
| References | 1.Seeliger H. P. R., and Jones D., 1986, Bergeys Manual of Systematic Bacteriology, Vol. The Williams and Wilkins Co.,Baltimore.2.Nieman R. E., and Lorber B., 1980, Rev. Infect. Dis. 2 : 207-227.3.Schuchat A. B., Swaminathan and C. V. Broome, Clin. Microbiol. Rev. 4: 169-183.4.Murray P. R., Baron E. J., Jorgensen J. H., Pfaller M. A., Yolken R. H., (Eds.), 8th Ed., 2003, Manual of Clinical Microbiology,ASM, Washington, D.C.5.Lovette J., Francis D.W. and Hunt J.M., 1987, J. Food Prot., 50:188.6.Lee W.K. and McClain D., 1986, Appl. Environ. Microbiol., 52:1215.7.McClain D. and Lee W.H., 1988, J. Assoc. Off. Anal. Chem., 71:660.8.Cowart R. E. and Foster B. G., 1985, J. Infect. Dis.; 151:172.9.Fraser , J., and W. Sperber. 198 |
| Customized Product Available | No |
















